D4DR Antibodies

Santa Cruz Biotechnology features a diverse variety of D4DR monoclonal antibodies for targeting the D4 dopamine receptor. D4DR monoclonal antibodies support multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The D4 dopamine receptor plays a crucial role in the central nervous system, influencing numerous physiological processes such as mood regulation, cognition, and motor control. Understanding D4 dopamine receptor function has significant implications for neuropsychiatric disorders, including schizophrenia and attention deficit hyperactivity disorder (ADHD). Researchers can investigate dopamine signaling pathways using advanced detection methods like fluorescein isothiocyanate (FITC), phycoerythrin (PE), and horseradish peroxidase (HRP) conjugated secondary antibodies. Exploring D4 dopamine receptor mechanisms provides valuable insights into potential therapeutic strategies for various neurological conditions. Current research focuses on understanding how D4 dopamine receptor signaling affects neural circuit development and function. D4DR monoclonal antibodies from Santa Cruz Biotechnology enable scientists worldwide to advance our understanding of dopamine-related neurological disorders and potential treatments.